These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35308291)

  • 1. On Therapeutic Plasma Exchange Against Severe COVID-19-Associated Pneumonia: An Observational Clinical Study.
    Cegolon L; Einollahi B; Panahi Y; Imanizadeh S; Rezapour M; Javanbakht M; Nikpouraghdam M; Abolghasemi H; Mastrangelo G
    Front Nutr; 2022; 9():809823. PubMed ID: 35308291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in adults with severe COVID-19 infection.
    Khamis F; Al-Zakwani I; Al Hashmi S; Al Dowaiki S; Al Bahrani M; Pandak N; Al Khalili H; Memish Z
    Int J Infect Dis; 2020 Oct; 99():214-218. PubMed ID: 32585284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.
    Wardhani SO; Fajar JK; Soegiarto G; Wulandari L; Maliga HA; Ilmawan M; Merysa R; Simamora AB; Aini Q; Noviantari K; Lestari AW; Harnila MY; Syafi'i I; Djianzonie JAC; Siagian N; Nining S; Hanim RZ; Wahyuni W; Aulia F; Juliansyah J; Mahmud R; Tamara F; Mahendra AI; Wowor AC; Baladraf F; Hadinata PH; Ikkeputri A; Nadya H; Kartini DA; Husnah M; Nainu F; Harapan H
    F1000Res; 2021; 10():1280. PubMed ID: 35083038
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.
    Kamran SM; Mirza ZE; Naseem A; Liaqat J; Fazal I; Alamgir W; Saeed F; Saleem S; Nisar S; Yousaf MA; Khan AZ; Hussain M; Azam R; Hussain M; Khan KA; Jamal Y; Iftikhar R
    PLoS One; 2021; 16(1):e0244853. PubMed ID: 33411791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial.
    Faqihi F; Alharthy A; Abdulaziz S; Balhamar A; Alomari A; AlAseri Z; Tamim H; Alqahtani SA; Kutsogiannis DJ; Brindley PG; Karakitsos D; Memish ZA
    Int J Antimicrob Agents; 2021 May; 57(5):106334. PubMed ID: 33838224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.
    Beraud M; Hashami SA; Lozano M; Bah A; Keith P
    Transfus Apher Sci; 2022 Aug; 61(4):103433. PubMed ID: 35341691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection.
    Al-Hashami S; Khamis F; Al-Yahyay M; Al-Dowaiki S; Al-Mashaykhi L; Al-Khalili H; Chandwani J; Al-Salmi I; Al-Zakwani I
    J Clin Apher; 2022 Dec; 37(6):563-572. PubMed ID: 36102158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients: A single centre non-randomized controlled trial.
    Novacescu AN; Duma G; Buzzi B; Baditoiu LM; Bedreag O; Papurica M; Sandesc D; Sorescu T; Vlad D; Licker M
    Exp Ther Med; 2022 Jan; 23(1):76. PubMed ID: 34934447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.
    Patidar GK; Land KJ; Vrielink H; Rahimi-Levene N; Dann EJ; Al-Humaidan H; Spitalnik SL; Dhiman Y; So-Osman C; Hindawi SI
    Vox Sang; 2021 Aug; 116(7):798-807. PubMed ID: 33730761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plasma exchange: A potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit.
    Emeksiz S; Özcan S; Perk O; Uyar E; Çelikel Acar B; Kibar Gül AE; Özkaya Parlakay A; Özbek N; Ekici Tekin Z; Coşkun S; Aydın F; Çelikel E; Kavurt AV; Ece İ; Ok Bozkaya İ; Ertürk A; Güney D; Şenel E
    Transfus Apher Sci; 2021 Jun; 60(3):103119. PubMed ID: 33836934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange for COVID-19-associated hyperviscosity.
    Truong AD; Auld SC; Barker NA; Friend S; Wynn AT; Cobb J; Sniecinski RM; Tanksley CL; Polly DM; Gaddh M; Connor M; Nakahara H; Sullivan HC; Kempton C; Guarner J; Duncan A; Josephson CD; Roback JD; Stowell SR; Maier CL
    Transfusion; 2021 Apr; 61(4):1029-1034. PubMed ID: 33231313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
    Gokhale Y; Mehta R; Kulkarni U; Karnik N; Gokhale S; Sundar U; Chavan S; Kor A; Thakur S; Trivedi T; Kumar N; Baveja S; Wadal A; Kolte S; Deolankar A; Pednekar S; Kalekar L; Padiyar R; Londhe C; Darole P; Pol S; Gokhe SB; Padwal N; Pandey D; Yadav D; Joshi A; Badgujar H; Trivedi M; Shah P; Bhavsar P
    BMC Infect Dis; 2021 Mar; 21(1):241. PubMed ID: 33673818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Outcomes of Patients with Severe SARS-CoV-2 Infection after Therapeutic Plasma Exchange by Number of TPE Sessions.
    Porosnicu TM; Sandesc D; Jipa D; Gindac C; Oancea C; Bratosin F; Fericean RM; Kodimala SC; Pilut CN; Nussbaum LA; Sirbu IO
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of therapeutic plasma exchange in severe COVID-19 disease: A meta-analysis.
    Prakash S; Sahu A; Routray SS; Maiti R; Mitra JK; Mukherjee S
    Vox Sang; 2023 Jan; 118(1):49-58. PubMed ID: 36254849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial.
    Reis G; Moreira Silva EADS; Medeiros Silva DC; Thabane L; Singh G; Park JJH; Forrest JI; Harari O; Quirino Dos Santos CV; Guimarães de Almeida APF; Figueiredo Neto AD; Savassi LCM; Milagres AC; Teixeira MM; Simplicio MIC; Ribeiro LB; Oliveira R; Mills EJ;
    JAMA Netw Open; 2021 Apr; 4(4):e216468. PubMed ID: 33885775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.
    Lecronier M; Beurton A; Burrel S; Haudebourg L; Deleris R; Le Marec J; Virolle S; Nemlaghi S; Bureau C; Mora P; De Sarcus M; Clovet O; Duceau B; Grisot PH; Pari MH; Arzoine J; Clarac U; Boutolleau D; Raux M; Delemazure J; Faure M; Decavele M; Morawiec E; Mayaux J; Demoule A; Dres M
    Crit Care; 2020 Jul; 24(1):418. PubMed ID: 32653015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Therapeutic Plasmapheresis in SARS-CoV-2 Induced Cytokine Release Syndrome: A Retrospective Cohort Study on COVID-19 Patients.
    Jamil Z; Khan AA; Yousuf H; Khalid K; Abbasi SM; Waheed Y
    Int J Gen Med; 2022; 15():4907-4916. PubMed ID: 35585996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever.
    Beştepe Dursun Z; Korkmaz S; Türe Z; Kaynar L; Dursun A; Çelik İ
    J Clin Apher; 2021 Jun; 36(3):390-397. PubMed ID: 33485278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.